CORTEX TERMINAL — Live intelligence preview. Decision-grade outputs. Your feedback shapes what we build.

Cortex Terminal

Decision infrastructure in action. Daily briefings, entity watchlists, social intelligence monitoring, and hallucination containment — the intelligence layer your organization is missing.

March 31, 2026
Generated 06:00 UTC

Today's Briefing

Executive Summary: FDA issues updated guidance on AI-assisted drug labeling. Novo Nordisk announces Phase III results for next-gen GLP-1. Senate hearing on biosimilar pricing scheduled for April 8. Overall confidence: 92%.

Key Developments

FDA CDER issues draft guidance on AI-generated labeling claims for biologics
Regulatory Filing
Confirmed
Novo Nordisk Phase III trial for CagriSema shows 22.7% weight loss at 68 weeks
Clinical Trial Data
Confirmed
Senate HELP Committee to hold hearing on biosimilar interchangeability standards
Legislative
Inferred

Anomalies Detected

• Unusual spike in Eli Lilly GLP-1 mentions on social media (3.2x baseline)
• Patent filing activity for biosimilar manufacturing on March 27

Risk Alerts

⚠️ Moderate: Competitive pressure from new GLP-1 entrant increasing
⚠️ Low: Regulatory timeline risk for FDA CDER decision (April 15 expected)
12
Claims Verified
2
Claims Blocked
92%
Overall Confidence

Active Watchlist

Novo Nordisk
Escalation
📈
Last updated: 2 minutes ago
Pfizer
Stable
➡️
Last updated: 14 minutes ago
Moderna
De-escalation
📉
Last updated: 31 minutes ago
FDA CDER
Active
⚡
Last updated: 4 minutes ago
Eli Lilly
Escalation
📈
Last updated: 7 minutes ago
AbbVie
Stable
➡️
Last updated: 19 minutes ago

Hallucination Containment System

Confidence Breakdown

Confirmed (78%)
Inferred (15%)
Monitoring (5%)
Blocked (2%)

Verification Model Chain

Model A (Primary)
Model B (Verifier)
Model C (Tie-break)
Recent Blocked Claims
Claim: "Moderna Phase II results show 98% efficacy" — Blocked: No published data found, confidence below threshold
Claim: "FDA approved new biosimilar on March 30" — Blocked: Timeline inconsistency, approval date not verified

Alert Preferences

Email Alerts

Receive daily intelligence digest

Critical Alerts

Immediate notification for high-risk developments

Watchlist Changes

Updates when monitored entities change status

Anomaly Detection

Alerts for unusual activity patterns

Are You a Healthcare Professional? Join the FHIN Network

Help advance the intelligence ecosystem while building professional credentials and earning platform credits. Your insights are cited in our reports and directly shape what intelligence your peers see.

Contributor Benefits
⭐
Platform Credits — Earn credits toward your subscription
📊
Impact Metrics — Track how your contributions influence the platform
✓
Verified Badge — Display your professional credentials
🔒
Anonymous Option — Contribute under "Verified Anonymous Member" label
Data contributions are cited with your name and credentials unless you choose the anonymous option. Anonymous contributors are tracked internally but publicly labeled as "Verified Anonymous Member" to maintain trust in the intelligence network.
Join FHIN